FDA approves Marathon Pharmaceuticals DMD drug
February 09, 2017 at 14:16 PM EST
Feb 9 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Marathon Pharmaceuticals' Duchenne muscular dystrophy (DMD) drug, Emflaza, to treat patients aged 5 years and above.
